Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
04 March 2019 | Story Valentino Ndaba
Next Chapter calls upon you to stay true to yourself by taking care of your mental well-being.

As the academic year kicks off, the University of the Free State gives a warm welcome to first-year and returning students. In the spirit of healthy new beginnings, Next Chapter has penned a letter to fellow students that speaks to mental health. Hear what they have to say:

Be loyal to your calling and the universe will locate you; once located, dominate! Fellow Kovsies, it is really happening. Not so long ago, this was just a dream – and somewhat far-fetched.

This is your moment; be at ease and feel at home, because you’re about to become a long-term tenant in a prestigious community of diversity, love, care, family, greatness, and prosperity. With that said, I welcome the class of 2019 to a community of brilliant minds. Bear in mind that all of us want to be part of such a community, but only a few get to make it – so, be very proud of yourselves.

Tap into endless possibilities

Now that you are here, know that everything is at your fingertips; you have the upper hand, and everything is now made possible. This is a moment for growth, to reinvent yourself, and expect the greatest confusion of your life as your mind and feelings will be tested and conflicted. Here is where you learn and unlearn certain things about your community and the world around you. So, please take this opportunity to explore, engage, participate, and where you can, mark your territory and dominate.

University can be tough as you face adversities and struggle to cope with juggling your grades and a social life. Find comfort in the knowledge that these are temporary circumstance you need to contend with. You are destined to emerge at the top.

Never succumb to the urge of givingup

There will be days when your subconscious fails you, there will be days when discontinuing your academics and heading back home is tempting. Do not to give in. Do not give up. You are here for a reason. Think about the twelve years of your life spent preparing for this moment. Some of you are going to struggle with academics, social life, finances, and conflicted minds which will hinder you in focusing on your academics. Seek help when you struggle.

Surround yourself with positive people who always bring out the best in you. There are avenues available to you, such as the psychologist sessions offered by Kovsie Health, and social workers who are there to help with various issues.

Support is at your disposal

Mentorship programmes such as Gateway are also at your disposal as a first-year student adjusting to a new environment. Student Life is always there for you in times of need. Next Chapter is a student organisation that advocates for mental health and can assist as well should you need support.

From us as Next Chapter to you as fellow students, we would like to officially welcome and encourage you to make the best of this experience. Be loyal to your calling, which has led you to the University of the Free State – and never forget that you matter. This is the beginning of something great and the continuing of your story.

News Archive

Nuclear Medicine on the forefront of cancer research
2017-07-10

Description: Nuclear Medicine on the forefront of cancer research Tags: Nuclear Medicine, cancer research, Dr Je’nine Horn-Lodewyk’s, tumour detection method, cancer, Department of Nuclear Medicine 

Dr Je’nine Horn-Lodewyk’s tumour detection method
could be the cost-effective breakthrough needed to decrease
the mortality rate in breast cancer patients.
Photo: Anja Aucamp

The field of Nuclear Medicine in South Africa and the rest of the world are expanding rapidly due to the development of hybrid cameras and new radiopharmaceuticals. These developments have a huge impact on the diagnosis and therapy of cancer.

The most advanced of these cameras, Positron emission tomography combined with normal CTs (PETCT), are not yet widely available in South Africa due to the cost of the cameras and the radiopharmaceuticals. A more cost-effective alternative can be of great benefit. To achieve this, the focus should be on developing new radiopharmaceuticals that can be used with the current cost-effective gamma cameras, according to University of the Free State researcher, Dr Je’nine Horn-Lodewyk from the Department of Nuclear Medicine.

Fluorodeoxyglucose (18F-FDG), a radiolabelled glucose analogue, is currently the radiopharmaceutical most commonly used in PET/CT imaging for mainly oncology indications. Although it is considered the gold standard for imaging in several malignancies, it does have certain disadvantages. An 18F-FDG PET/CT diagnostic imaging study can cost between R25 000 and R35 000 for a single patient in the private sector. The 18F-FDG is also more radioactive, which requires much stricter handling and shielding to avoid high radiation dosages to staff and patients.

Successful research potential innovative solution
In the search for the ideal radiopharmaceutical for tumour detection, the South African National Nuclear Energy Corporation (Necsa) developed a local synthesis process for ethylenedicysteine-deoxyglucose (EC-DG). EC-DG is also a glucose analogue similar to FDG. They succeeded in labelling the compound with Technetium-99-metastable-pertechnetate (99mTcO4-), the most common nuclear medicine isotope used for approximately 95% of nuclear medicine procedures, creating 99mTc-EC-DG.

In partnership with Dr Horn-Lodewyk, this compound was successfully used in various animal models and clinical scenarios, resulting in approval by the Medicine Control Council to use it in a human study. Research is also planned in order to investigate diagnostic accuracy in other cancers like lymphoma.  The end result of this research can produce a radiopharmaceutical that is cost effective, does not require the use of costly specialised equipment, has no significant side-effects, no special patient preparation, renders late imaging possible, and has decreased radiation risks.

Dr Horn-Lodewyk is grateful for the support of her mentor, Prof Anton Otto, as well as Dr Gert Engelbrecht, Head of the Department of Nuclear Medicine, Prof Jan Rijn Zeevaart from North-West University’s Preclinical Drug Development Platform and Necsa, and Judith Wagener from Necsa. This innovative research would also not have been possible without the financial assistance of Dr Glen Taylor and Eleanor van der Westhuizen in the Directorate of Research Development.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept